Tamer El Saadany
Chur, GR, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Immune-related adverse events of immune checkpoint inhibitors
Journal: Therapeutische Umschau. Revue therapeutique
Published: September 01, 2026
KRAS-mutated Non-Small Cell Lung Cancer: Drugging the Undruggable.
Journal: Cancer journal (Sudbury, Mass.)
Published: May 27, 2026
KRASG12C inhibitor combination therapy in metastatic non-small-cell lung cancer: choosing the right path.
Journal: The Lancet. Oncology
Published: March 02, 2026
A cost-effectiveness analysis of sotorasib as second-line treatment for patients with KRAS-G12C-mutated metastatic non-small cell lung cancer (mNSCLC) in Switzerland.
Journal: Swiss medical weekly
Published: January 21, 2025
PD-L1 expression and correlation with outcome in muscle-invasive and metastatic urothelial carcinoma: review and critical discussion.
Journal: Frontiers in oncology
Published: May 03, 2024
Bedside manufacturing as the next step in personalized medicine: medical progress and legal challenges.
Journal: Journal of law and the biosciences
Published: January 17, 2024
microRNA-206 modulates the hepatic expression of the organic anion-transporting polypeptide 1B1.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 26, 2019
Sex-specific effects of leisure-time physical activity on cause-specific mortality in NHANES III.
Journal: Preventive medicine
Published: January 05, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026